All ProductsDisplaying Products Alphabetically by Name (P)
Cat. No. | Product Name / Activity |
---|---|
4485 | P 22077 |
USP7 inhibitor | |
5760 | P-3FAX-Neu5Ac |
Sialic acid analog; sialyltransferase inhibitor | |
6897 | P110 |
Dynamin-related protein 1 (Drp1) inhibitor; cell-permeable | |
7974 | P3S |
Reagent for modifying RNA at 2'-OH position, for SHAPE-MAP experiments | |
4076 | P7C3 |
NAMPT activator; also proneurogenic and neuroprotective | |
6657 | PA 8 |
PAC1 receptor antagonist | |
6149 | PA Janelia Fluor® 549, NHS ester |
Yellow photoactivatable dye (Reactive group: NHS ester). Application: super resolution microscopy (SRM), single molecule tracking and live cell imaging | |
8815 | PA Janelia Fluor® 646, Haloalkane New |
Photoactivatable Janelia Fluor® 646 with chloroalkane handle for self-labeling tags fusion protein | |
6150 | PA Janelia Fluor® 646, NHS ester |
Red photoactivatable dye (Reactive group: NHS ester). Application: super resolution microscopy (SRM), single molecule tracking and live cell imaging | |
6700 | PA Nic |
Caged nicotine; photoactivated by one-photon and two-photon excitation | |
2581 | PAC 1 |
Activator of procaspase-3; pro-apoptotic | |
1183 | PACAP 1-27 |
Potent stimulator of adenylyl cyclase | |
1186 | PACAP 1-38 |
Potent stimulator of adenylyl cyclase | |
3236 | PACAP 6-38 |
Potent PAC1 receptor antagonist | |
5116 | PACMA 31 |
Irreversible protein disulfide isomerase (PDI) inhibitor | |
2940 | PAF (C16) |
Endogenous platelet-activating factor (PAF) | |
7994 | PAG 3'-fluoro-4'-piperazine |
Functionalized cereblon ligand for PROTAC development | |
7996 | PAG 3'-piperazine |
Functionalized cereblon ligand for PROTAC development | |
7997 | PAG 3'-piperazine-4-methylpiperidine New |
Cereblon ligand with terminal piperidine for onward chemistry | |
7998 | PAG 4'-piperazine |
Functionalized cereblon ligand for PROTAC development | |
7999 | PAG 4'-piperazine-4-methylpiperidine |
Cereblon ligand with terminal piperidine for onward chemistry | |
6551 | PAMP-12 (human, porcine) |
Potent MRGPRX2 agonist | |
6552 | PAMP-20 (human) |
MRGPRX2 agonist; also non-competitive nAChR antagonist | |
7410 | PARPYnD |
PARP inhibitor; photoaffinity probe | |
6461 | PARPi-FL |
Potent fluorescent PARP inhibitor; cell permeable | |
2562 | PB 28 dihydrochloride |
High affinity σ2 agonist | |
5564 | PBS, 100 Tablets |
PBS Tablets | |
5012 | PCI 29732 |
Potent BTK inhibitor | |
4643 | PCI 34051 |
Potent and selective HDAC8 inhibitor | |
4192 | PD 0325901 |
Potent inhibitor of MEK1/2 | |
4786 | PD 0332991 isethionate |
Potent cdk4 and cdk6 inhibitor; brain penetrant | |
1671 | PD 102807 |
Selective M4 antagonist | |
1361 | PD 123319 ditrifluoroacetate |
Potent and selective non-peptide AT2 antagonist | |
1243 | (+)-PD 128907 hydrochloride |
High affinity D3 agonist (D3 ≥ D2 > D4) | |
2850 | PD 146176 |
Selective 15-lipoxygenase inhibitor | |
1269 | PD 150606 |
Cell permeable calpain inhibitor | |
2615 | PD 158780 |
Potent ErbB receptor family inhibitor | |
3724 | PD 161570 |
Selective FGFR inhibitor | |
3785 | PD 166285 dihydrochloride |
Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1 | |
2520 | PD 166793 |
Broad spectrum MMP inhibitor | |
1065 | PD 168077 maleate |
High affinity, selective D4 agonist | |
3529 | PD 168568 dihydrochloride |
Potent and selective D4 antagonist | |
3044 | PD 173074 |
FGFR1 and -3 inhibitor | |
2602 | PD 176252 |
GRP (BB2) and NMB (BB1) receptor antagonist | |
4237 | PD 184352 |
Selective MEK inhibitor | |
2605 | PD 198306 |
Selective inhibitor of MEK1/2 | |
4824 | PD 334581 |
MEK1 inhibitor | |
7858 | PD 4'-oxyacetic acid |
Functionalized cereblon ligand for PROTAC development | |
7859 | PD 4'-piperazine |
Stable cereblon ligand, for PROTAC synthesis | |
2694 | PD 407824 |
Potent and selective inhibitor of Chk1 and Wee1 | |
1363 | PD 81723 |
Positive allosteric modulator of A1 receptors | |
1213 | PD 98059 |
MEK inhibitor | |
0298 | L-trans-2,4-PDC |
Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor | |
7007 | PDD 00017238 |
High affinity and potent PARG inhibitor | |
7006 | PDD 00017272 |
Potent PARG inhibitor | |
5952 | PDD 00017273 |
Potent and selective PARG inhibitor; cell permeable | |
8824 | PDEδ ATTEC 12C New |
PDEδ autophagy-tethering compound (ATTEC) Degrader | |
7868 | PE 22-28 |
Potent inhibitor of TREK-1 channels | |
5018 | PEAQX tetrasodium salt |
Potent and GluN2A-selective NMDA antagonist | |
7854 | PEI STAR™ transfection reagent |
Polyethylenimine (PEI) transfection reagent, chemically-defined | |
8174 | PEI STAR-Go™ transfection reagent New |
Aqueous solution of polyethylenimine (PEI) transfection reagent | |
6308 | PEN (mouse) |
GPR83 agonist | |
4054 | PEP 005 |
Protein kinase C activator | |
4239 | PF 04217903 mesylate |
Highly selective MET inhibitor | |
4818 | PF 04418948 |
Potent and selective EP2 receptor antagonist | |
5915 | PF 04449613 |
Potent PDE9 inhibitor; brain penetrant | |
6538 | PF 04449913 maleate |
Potent Smo antagonist | |
6374 | PF 04457845 |
Potent and selective irreversible FAAH inhibitor | |
5755 | PF 04479745 |
Potent and selective 5-HT2C agonist | |
5863 | PF 04620110 |
Potent and selective DGAT-1 inhibitor; orally bioavailable | |
6347 | PF 04628935 |
Potent ghrelin receptor inverse agonist | |
6024 | PF 04671536 hydrochloride |
Potent and selective PDE8B/8A inhibitor | |
4916 | PF 04885614 |
Potent and selective NaV1.8 channel blocker; active in vivo | |
5931 | PF 05089771 |
Potent and selective Nav1.7 channel blocker | |
5790 | PF 05175157 |
Potent acetyl-CoA carboxylase (ACC) 1 and 2 inhibitor | |
6405 | PF 05180999 |
Potent and selective PDE2A inhibitor | |
6350 | PF 05190457 |
High affinity and selective ghrelin receptor inverse agonist | |
5752 | PF 06260933 dihydrochloride |
MAP4K4 (HGK) inhibitor; also inhibits MINK and TNIK | |
6115 | PF 06273340 |
Potent and selective pan-Trk inhibitor; peripherally restricted | |
6004 | PF 06281355 |
Selective myeloperoxidase (MPO) inhibitor | |
6114 | PF 06409577 |
Potent and selective allosteric activator of AMPK | |
6348 | PF 06424439 |
Potent and selective DGAT2 inhibitor | |
4710 | PF 06465469 |
Potent ITK inhibitor; also inhibits BTK | |
6506 | PF 06551600 malonate |
Potent and selective JAK3 inhibitor | |
6169 | PF 06726304 acetate |
Highly potent and SAM-competitive EZH2 inhibitor | |
4238 | PF 184 |
Potent and selective IKKβ inhibitor | |
5751 | PF 3084014 hydrobromide |
Potent γ-secretase inhibitor | |
4279 | PF 3644022 |
Potent MK2 inhibitor | |
6005 | PF 3758309 dihydrochloride |
Potent PAK4 inhibitor; orally available | |
4175 | PF 3845 |
Selective FAAH inhibitor | |
3354 | PF 429242 dihydrochloride |
Competitive inhibitor of SREBP site 1 protease | |
4278 | PF 431396 |
Dual FAK/PYK2 inhibitor | |
4032 | PF 4708671 |
S6K1 inhibitor | |
4277 | PF 477736 |
Selective Chk1 inhibitor | |
4281 | PF 4800567 hydrochloride |
Selective casein kinase 1ε inhibitor | |
6346 | PF 5006739 |
Potent CK1δ/ε inhibitor | |
5262 | PF 5274857 hydrochloride |
High affinity and selective Smoothened (Smo) receptor antagonist | |
3239 | PF 573228 |
Potent and selective FAK inhibitor | |
3316 | PF 670462 |
Potent and selective CK1ε and CK1δ inhibitor | |
3291 | PF 915275 |
Potent and selective 11β-hydroxysteroid dehydrogenase inhibitor | |
4445 | PFI 1 |
BET bromodomain inhibitor | |
4892 | (R)-PFI 2 hydrochloride |
Potent and selective SETD7 inhibitor | |
5400 | (S)-PFI 2 hydrochloride |
Negative control of (R)-PFI 2 hydrochloride (Cat. No. 4892) | |
5072 | PFI 3 |
Potent and selective SMARCA2/4 and polybromo 1 inhibitor | |
7963 | PFI 653 |
Potent and selective vanin 1 inhibitor | |
5339 | PFK 15 |
Selective PFKFB3 inhibitor | |
3887 | PG 01037 dihydrochloride |
Selective D3 antagonist | |
5866 | PH 797804 |
Potent and selective p38α/β inhibitor | |
3092 | PHA 543613 hydrochloride |
Potent and selective α7 nAChR agonist | |
3134 | PHA 568487 |
Selective α7 nAChR agonist | |
2693 | PHA 665752 |
Potent and selective MET inhibitor | |
3140 | PHA 767491 hydrochloride |
Cdk inhibitor; potently inhibits cdk9; also inhibits MK2 | |
1027 | PHCCC |
Potent group I mGlu antagonist | |
6771 | PHPS1 sodium salt |
Shp2 (PTPN11) inhibitor | |
2662 | PHTPP |
Selective ERβ antagonist | |
2930 | PI 103 hydrochloride |
Inhibitor of PI 3-kinase, mTOR and DNA-PK | |
2814 | PI 828 |
PI 3-kinase inhibitor, more potent than LY 294002 (Cat. No. 1130) | |
7902 | PIK 90 |
Potent PI3K inhibitor, also used in hPSCs mesendoderm differentiation | |
3255 | PJ 34 hydrochloride |
Potent PARP inhibitor | |
5338 | PK-THPP |
Potent K2P9.1 (TASK-3) channel blocker | |
1904 | PKA inhibitor fragment (6-22) amide |
Potent protein kinase A inhibitor | |
6221 | PKI (5-24) |
High affinity PKA inhibitor | |
2546 | PKI 14-22 amide, myristoylated |
Cell-permeable protein kinase A inhibitor | |
4941 | PKI 166 hydrochloride |
Potent EGFR-kinase inhibitor | |
6238 | PKRA 7 |
Potent prokineticin (PK) 1 and 2 receptor antagonist; antitumor; BBB penetrant | |
6580 | PKUMDL WQ 2101 |
Negative allosteric modulator of 3-phosphoglycerate dehydrogenase (PHGDH) | |
6581 | PKUMDL WQ 2201 |
Negative allosteric modulator of 3-Phosphoglycerate dehydrogenase (PHGDH) | |
2567 | PLP (139-151) |
Encephalitogenic myelin proteolipid fragment | |
7505 | PLpro inhibitor 19 |
SARS-CoV-2 PLpro and replication inhibitor | |
7357 | PLpro inhibitor 6 |
SARS-CoV and SARS-CoV-2 PLpro inhibitor | |
1380 | PMPA (NAALADase inhibitor) |
GCP II inhibitor | |
4486 | PMSF |
Non-selective protease inhibitor; also blocks anandamide metabolism | |
5196 | PMX 205 |
Potent C5a receptor peptide antagonist | |
5473 | PMX 53 |
Potent C5a receptor antagonist | |
5697 | PMX 53c |
Negative control for PMX 53 (Cat. No. 5473) | |
6891 | PND 1186 |
Potent FAK inhibitor; orally bioavailable | |
2498 | PNU 120596 |
Positive allosteric modulator of α7 nAChRs; active in vivo | |
1985 | PNU 142633 |
Highly selective 5-HT1D agonist | |
2303 | PNU 282987 |
Selective α7 nAChR agonist | |
2095 | PNU 37883 hydrochloride |
Vascular Kir6 (KATP) channel blocker | |
3534 | PNU 74654 |
β-catenin binder; inhibits Wnt signaling | |
2689 | POM 1 |
Inhibitor of E-NTPDases | |
1397 | PP 1 |
Potent, selective Src family kinase inhibitor | |
3894 | PP 121 |
Dual kinase inhibitor; inhibits PI 3-K family kinases | |
1407 | PP 2 |
Potent, selective Src family kinase inhibitor | |
4257 | PP 242 |
Dual mTORC1/mTORC2 inhibitor | |
2794 | PP 3 |
Negative control for PP 2 (Cat. No. 1407) | |
6515 | (D)-PPA 1 |
PD-1/PD-L1 interaction inhibitor | |
0625 | PPADS tetrasodium salt |
Non-selective P2 antagonist | |
0683 | iso-PPADS tetrasodium salt |
Non-selective P2X antagonist | |
0620 | 4-PPBP maleate |
Specific σ ligand, NMDA antagonist | |
3870 | (±)-PPCC oxalate |
Selective sigma (σ) agonist (σ1> σ2) | |
2530 | PPDA |
GluN2C/GluN2D-selective NMDA antagonist | |
1034 | 4-P-PDOT |
MT2 antagonist | |
1426 | PPT |
Subtype-selective ERα agonist | |
4862 | PPTN hydrochloride |
High affinity and selective P2Y14 antagonist | |
4730 | PPY A |
Potent inhibitor of Abl T315l mutant and wild-type Abl kinases | |
2768 | PQ 401 |
IGF1R inhibitor | |
4482 | PR 619 |
Broad spectrum DUB inhibitor | |
0589 | PRE-084 hydrochloride |
Highly selective σ1 agonist | |
3710 | PRIMA-1MET |
Restores mutant p53 activity | |
8004 | PROTAC®(H-PGDS)-7 |
Potent hematopoietic prostaglandin D2 synthase Degrader (PROTAC®) | |
8005 | PROTAC®(H-PGDS)-8 |
Negative control for PROTAC®(H-PGDS)-7 (Cat. No. 8004) | |
5047 | PRT 4165 |
Inhibitor of Bmi1/Ring1A; blocks histone H2A ubiquitination | |
6748 | PRX 07034 |
Potent and selective 5-HT6 antagonist | |
2573 | PSB 069 |
Non-selective NTPDase inhibitor | |
3983 | PSB 0739 |
Highly potent P2Y12 antagonist | |
4334 | PSB 0777 ammonium salt |
Potent adenosine A2A agonist | |
3199 | PSB 0788 |
Selective A2B antagonist | |
2010 | PSB 10 hydrochloride |
Potent, highly selective hA3 receptor antagonist/inverse agonist | |
4333 | PSB 1114 |
Potent, selective P2Y2 agonist | |
2009 | PSB 1115 |
Selective human A2B antagonist; water-soluble | |
6083 | PSB 12379 |
Ecto-5'-nucleotidase (CD73) inhibitor | |
3198 | PSB 603 |
Highly selective A2B antagonist | |
6372 | PSB CB5 |
Selective GPR18 antagonist | |
4042 | PSC 833 |
Inhibitor of P-gp-mediated MDR | |
6425 | PSEM 308 hydrochloride |
PSAML141F-GlyR and PSAML141F,Y115F-5-HT3 chimeric ion channel agonist | |
6426 | PSEM 89S |
PSAML141F-GlyR and PSAML141F,Y115F-5-HT3 chimeric ion channel agonist | |
5321 | PSNCBAM-1 |
Negative allosteric modulator of CB1 receptors | |
7651 | PT-65 |
Potent GSK3 Degrader (PROTAC®) | |
2954 | PX 12 |
Thioredoxin-1 inhibitor | |
2978 | PYR 41 |
Ubiquitin-activating enzyme (E1) inhibitor | |
7876 | PZ 3022 |
PanK Activator | |
7218 | PZM21 |
Selective μ receptor agonist | |
4493 | Paliperidone |
5-HT2A antagonist; also D2 antagonist; atypical antipsychotic | |
0879 | Palmitoylethanolamide |
Selective GPR55 agonist. FAAH and PAA substrate | |
7038 | Palonosetron hydrochloride |
Highly potent and high affinity 5-HT3 antagonist | |
4637 | Pam2CSK4 |
TLR2/6 agonist; induces TNF-α production | |
4633 | Pam3CSK4 |
TLR1/2 agonist; induces cytokine production | |
1154 | Pancreatic Polypeptide (human) |
NPY Y4 agonist; involved in gastrointestinal tract function | |
7629 | Panobinostat |
Pan-histone deacetylase inhibitor | |
6301 | Parathyroid hormone (1-34) (rat) |
Parathyroid hormone (PTH) receptor agonist | |
3011 | Parathyroid hormone (1-34) (human) |
Parathyroid hormone (PTH) receptor agonist | |
2141 | Paroxetine maleate |
Highly potent and selective 5-HT uptake inhibitor | |
2006 | Paxilline |
SERCA ATPase blocker. Also potent BKCa channel blocker | |
6349 | Pelitinib |
Potent and irreversible EGFR inhibitor; orally bioavailable | |
6185 | Pemetrexed |
Thymidylate synthetase inhibitor, also inhibits dihydrofolate reductase, GARFT and AICART | |
4617 | Penitrem A |
Potent and selective KCa1.1 (BK) channel blocker | |
2033 | Pentostatin |
Adenosine deaminase inhibitor | |
2687 | Pentylenetetrazole |
CNS stimulant | |
6423 | Pep 2-8 |
Potent PCSK9 inhibitor | |
1190 | Pepstatin A |
Selective and high affinity cathepsin D inhibitor | |
7314 | Pepstatin A Janelia Fluor® 526 |
Fluorogenic green-emitting lysosome tracker and stain | |
1618 | Peptide YY (3-36) |
Selective NPY Y2 receptor agonist | |
5166 | Perhexiline maleate |
Carnitine palmitoyltransferase 1 and 2 (CPT1/2) inhibitor | |
6087 | Perifosine |
PKB/Akt inhibitor; also modulates Kv2.1 current | |
5549 | Perlapine |
Potent hM3Dq and hM4Di DREADD agonist in vitro | |
4944 | Peroxy Orange 1 |
Fluorescent hydrogen peroxide indicator | |
3097 | Pertussis Toxin |
Catalyzes ADP-ribosylation of Gi, Go and Gt | |
6451 | Pexacerfont |
Potent and selective CRF1 antagonist; anxiolytic | |
7590 | Pexidartinib |
Potent CSF-1R inhibitor | |
7392 | 5-Ph-IAA |
Selective and potent TAG Degrader for auxin-inducible degron 2 system | |
4535 | Phalloidin |
Promotes actin polymerization | |
5782 | Phalloidin-FITC |
Green-fluorescent cytoskeleton stain. Binds and labels F-actin. Used for: F-actin staining. Application: fluorescent microscopy, immunofluorescence (IHC, ICC) | |
7201 | Phalloidin-Janelia Fluor® 646 |
Red-fluorescent F-actin probe. Binds and labels F-actin. Used for: F-actin labelling. Application: confocal microscopy, super resolution microscopy (SRM) including dSTORM & STED, flow cytometry | |
5783 | Phalloidin-TRITC |
Red-orange fluorescent cytoskeleton stain. Binds and labels F-actin. Used for: F-actin staining. Application: fluorescent microscopy, immunofluorescence (IHC, ICC) | |
7873 | Phen Green SK diacetate |
Heavy metal ion indicator, membrane permeable | |
3379 | Phenamil |
Inhibits TRPP3-mediated currents; also inhibits epithelial Na+ channels | |
2557 | Phencyclidine hydrochloride |
Non-competitive NMDA antagonist | |
6431 | Phentolamine Mesylate |
Adrenergic α receptor antagonist; antihypertensive | |
7729 | Phenyl-glutarimide 4'-piperazine |
Piperazine-functionalized cereblon ligand for PROTAC development | |
7670 | Phenyl-glutarimide 4'-oxyacetic acid |
Functionalized cereblon ligand for PROTAC development | |
2682 | Sodium 4-Phenylbutyrate |
Histone deacetylase inhibitor | |
2838 | (R)-(-)-Phenylephrine hydrochloride |
α1 agonist | |
0680 | 2-Phenylmelatonin |
Potent melatonin agonist | |
4153 | Phorbol 12,13-dibutyrate |
Protein kinase C activator | |
1201 | Phorbol 12-myristate 13-acetate |
Protein kinase C activator | |
4995 | Phortress |
Prodrug of the antitumor agent 5F 203 | |
5778 | 2-Phospho-L-ascorbic acid trisodium salt |
Ascorbic acid derivative; maintains differentiation potential in bone marrow-derived MSCs | |
4325 | Phosphocreatine disodium salt |
Phosphate reservoir | |
6333 | Phosphoramidon disodium salt |
Neutral endopeptidase and endothelin converting enzyme inhibitor | |
7328 | Photo-lenalidomide-acid |
Functionalized photoswitchable cereblon ligand for Degraders | |
7362 | Phototrexate |
Photoswitchable inhibitor of human dihydrofolate reductase | |
4914 | Phrixotoxin 3 |
Potent blocker of NaV1.2, NaV1.3 and NaV1.5 channels | |
0622 | Physostigmine hemisulfate |
Cholinesterase inhibitor | |
1554 | Piceatannol |
Inhibits TNF-induced NF-κB activation | |
4525 | Piclamilast |
Potent and selective PDE4 inhibitor | |
2956 | Picropodophyllotoxin |
Selective IGF1R inhibitor | |
1128 | Picrotoxin |
GABAA antagonist | |
1267 | Pifithrin-α hydrobromide |
p53 inhibitor. Also aryl hydrocarbon receptor agonist | |
3843 | Cyclic Pifithrin-α hydrobromide |
p53 inhibitor | |
2653 | Pifithrin-μ |
Inhibitor of p53-mitochondrial binding | |
0694 | Pilocarpine hydrochloride |
Muscarinic agonist | |
7667 | Pimavanserin |
Selective 5-HT2A inverse agonist | |
6182 | Pimonidazole |
Hypoxia detection reagent | |
0937 | Pimozide |
D2-like antagonist; also high affinity 5-HT7 antagonist | |
4124 | Pioglitazone hydrochloride |
Selective PPARγ agonist; antidiabetic agent | |
1093 | Pirfenidone |
Antifibrotic agent; regulates cytokine levels in vivo | |
4942 | Pitavastatin calcium |
HMG-CoA reductase inhibitor | |
6070 | Pladienolide B |
mRNA splicing inhibitor; antitumor | |
4847 | PluriSln 1 |
SCD-1 inhibitor | |
4287 | Poly(I:C) |
TLR3 agonist | |
7739 | Polyamine Supplement x1000 (lyophilized) |
Media supplement to boost cell growth; used as component of CEPT cocktail to enhance stem cell viability | |
7711 | Polybrene |
Viral transduction enhancer | |
3197 | Polygodial |
TRPA1 channel activator; analgesic and antifungal | |
6302 | Pomalidomide |
Cereblon binder; also TNF-α inhibitor and antiangiogenic | |
7094 | Pomalidomide 4'-PEG1-acid |
Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
7203 | Pomalidomide 4'-PEG1-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7434 | Pomalidomide 4'-PEG1-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7212 | Pomalidomide 4'-PEG2-acid |
Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
6637 | Pomalidomide 4'-PEG2-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7307 | Pomalidomide 4'-PEG2-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
6681 | Pomalidomide 4'-PEG3-acid |
Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
7204 | Pomalidomide 4'-PEG3-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7435 | Pomalidomide 4'-PEG3-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7213 | Pomalidomide 4'-PEG4-acid |
Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
6963 | Pomalidomide 4'-PEG4-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7436 | Pomalidomide 4'-PEG4-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7095 | Pomalidomide 4'-PEG5-acid |
Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
7924 | Pomalidomide 4'-PEG5-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7437 | Pomalidomide 4'-PEG5-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7732 | Pomalidomide 4'-alkylC10-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6851 | Pomalidomide 4'-alkylC2-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7439 | Pomalidomide 4'-alkylC2-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7096 | Pomalidomide 4'-alkylC3-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7205 | Pomalidomide 4'-alkylC3-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7440 | Pomalidomide 4'-alkylC3-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7209 | Pomalidomide 4'-alkylC4-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7441 | Pomalidomide 4'-alkylC4-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
6682 | Pomalidomide 4'-alkylC5-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
6716 | Pomalidomide 4'-alkylC5-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7442 | Pomalidomide 4'-alkylC5-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7210 | Pomalidomide 4'-alkylC6-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7923 | Pomalidomide 4'-alkylC6-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7443 | Pomalidomide 4'-alkylC6-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7097 | Pomalidomide 4'-alkylC7-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7208 | Pomalidomide 4'-alkylC7-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7211 | Pomalidomide 4'-alkylC8-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
6944 | Pomalidomide 4'-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7470 | Pomalidomide 5'-fluoro-6'-piperazine |
Cereblon ligand with terminal piperazine for onward chemistry | |
7471 | Pomalidomide 5'-fluoro-6'-piperazine-4-methylpiperidine |
Cereblon ligand with terminal piperidine for onward chemistry | |
7468 | Pomalidomide 5'-piperazine |
Cereblon ligand with terminal piperazine for onward chemistry | |
7469 | Pomalidomide 5'-piperazine-4-methylpiperidine |
Cereblon ligand with terminal piperidine for onward chemistry | |
7913 | Pomalidomide 5'-piperidine-acid |
Cereblon ligand with piperidine linker and terminal acid for onward chemistry | |
5225 | Ponceau S Staining Solution |
Stain used to detect protein bands after Western blotting | |
4174 | Pramipexole dihydrochloride |
Selective D3 agonist | |
5031 | Pramlintide |
Synthetic version of amylin (Cat. No. 3418) | |
6317 | Prasugrel |
Irreversible P2Y12 antagonist; antiplatelet and orally active | |
2318 | Pravastatin sodium salt |
HMG-CoA reductase inhibitor | |
0623 | Prazosin hydrochloride |
α1 and α2B antagonist; also MT3 antagonist | |
3652 | Pregnanolone |
Postitive allosteric modulator of GABAA receptors | |
5376 | Pregnenolone sulfate sodium salt |
NMDA potentiator; also GABAA inhibitor and TRPM3 activator | |
7630 | Pridopidine |
Highly selective σ1 agonist | |
7321 | Pritelivir |
Potent and selective herpes simplex virus (HSV) helicase primase inhibitor | |
7361 | ProK |
Unnatural amino acid, propargyl lysine derivative | |
4023 | ProTx II |
Selective NaV1.7 channel blocker | |
4107 | Probenecid |
MRP and OAT3 inhibitor | |
1102 | Procaterol hydrochloride |
Potent β2 agonist | |
2835 | Progesterone |
Endogenous progesterone receptor agonist | |
1478 | Proglumide sodium salt |
Non-selective CCK antagonist; orally active | |
5135 | Propidium iodide |
Red-fluorescent DNA stain, membrane impermeant to live cells. Used for: apoptosis detection, nuclear counterstaining, viability staining. Application: flow cytometry, confocal microscopy, fluorescence microscopy | |
0624 | Propranolol hydrochloride |
β antagonist | |
0835 | (R)-(+)-Propranolol hydrochloride |
β antagonist. Less active enantiomer of propranolol (Cat. No. 0624) | |
0834 | (S)-(-)-Propranolol hydrochloride |
β antagonist. More active enantiomer of propranolol (Cat. No. 0624) | |
5151 | Prosaptide TX14(A) |
Potent GPR37 and GPR37L1 agonist | |
2296 | Prostaglandin E2 |
Promotes HSCs expansion; increases HSCs engraftment; also endogenous prostaglandin | |
4214 | Prostaglandin F2α |
Naturally-occurring prostanoid; potent vasoconstrictor | |
5500 | Protease Inhibitor Cocktail I |
Protease inhibitor cocktail for mammalian cells | |
8098 | ProtiFect STAR™ Protein Transfection Reagent |
Protein transfection reagent | |
5042 | Psalmotoxin 1 |
Potent and selective ASIC1a channel blocker | |
4367 | Psora 4 |
Potent KV1.3 channel blocker | |
6862 | Psoralen-triethylene glycol azide |
RNA conformation probe; reagent for COMRADES RNA platform | |
3384 | (Z)-Pugnac |
O-GlcNAcase and β-hexosaminidase inhibitor | |
4551 | Purmorphamine |
Smo receptor agonist | |
4089 | Puromycin dihydrochloride |
Protein synthesis inhibitor | |
1580 | Purvalanol A |
Cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 | |
1581 | Purvalanol B |
Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 | |
6941 | Pyr 10 |
Selective TRPC3 inhibitor | |
3751 | Pyr3 |
Selective TRPC3 inhibitor | |
6577 | Pyridone 6 |
Potent pan-JAK inhibitor; induces intermediate mesoderm; cell-permeable | |
4763 | Pyridostatin pentahydrochloride |
Stabilizes G-quadruplexes; induces DNA damage and cell cycle arrest | |
2478 | 2-Pyridylethylamine dihydrochloride |
H1 agonist | |
3918 | Pyrimethamine |
Potent inhibitor of multidrug and toxin extrusion (MATE) transporters; also DHFR and STAT3 inhibitor | |
4978 | Pyrintegrin |
Enhances survival of human ESCs following enzymatic dissociation |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800